Pregnancy Category C
Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.
1. Death AK, McGrath KC, Kazlauskas R, Handelsman DJ. Tetrahydrogestrinone is a potent androgen and progestin. J Clin Endocrinol Metab. 2004 May;89(5):2498-500
2. Catlin D. H., Sekera M. H., Ahrens B. D., Starcevic B., Chang Y. C., Hatton C. K. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom. 2004;18:1245049.
3. Yu-Chen Chang; Borislav Starcevic; Brian D. Ahrens; M. Jane Strouse; Don H. Catlin. Identification of a Urinary Metabolite of the Designer Steroid Tetrahydrogestrinone (THG). Drug Metab: Toxicology.
4. Fernand Labrie, Van Luu-The, Ezequiel Calvo, Cline Martel, Julie Cloutier, Sylvain Gauthier, Pascal Belleau, Jean Morissette, Marie-Hlne Lvesque, and Claude Labrie J. Endocrinol., Feb 2005; 184: 427 - 433.